Agnieszka Gogler-Pigłowska

Agnieszka Gogler-Pigłowska

Auto-generated profile, based on publicly available information

Agnieszka Gogler-Pigłowska

Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Institute-Oncology Center Gliwice Branch, Wybrzeże Armii Krajowej 15, 44-101, Gliwice, Poland

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Cellular Signalling
Verified
Journal Article
Open access
ATAgnieszka Toma-Jonik
Agnieszka Toma-Jonik
WWWiesława Widłak
Wiesława Widłak
JKJoanna Korfanty
Joanna Korfanty
TCTomasz Cichoń
Tomasz Cichoń
RSRyszard Smolarczyk
Ryszard Smolarczyk
NVnatalia vydra
natalia vydra
Heat shock transcription factor 1 (HSF1), the major regulator of stress response, is frequently activated in cancer and has an apparent role in malignant transformation. Here we analyzed the influence of the over-expression of a constitutively active transcriptionally-competent HSF1 mutant form on phenotypes of mouse and human melanoma cells. We observed that the expression of active HSF1 supported anchorage-independent growth in vitro, and metastatic spread in the animal model in vivo, although the proliferation rate of cancer cells was not affected. Furthermore, active HSF1 enhanced cell motility, reduced the adherence of cells to a fibronectin-coated surface, and affected the actin cytoskeleton. We found that although the expression of active HSF1 did not affect levels of epithelial-to-mesenchymal transition markers, it caused transcriptional down-regulation of vinculin, protein involved in cell motility, and adherence. Functional HSF1-binding sites were found in mouse and human Vcl/VCL genes, indicating a direct role of HSF1 in the regulation of this gene. An apparent association between HSF1-induced down-regulation of vinculin, increased motility, and a reduced adherence of cells suggests a possible mechanism of HSF1-mediated enhancement of the metastatic potential of cancer cells.

1 January 2011 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
ARAleksandra Rusin
Aleksandra Rusin
JZJadwiga Zawisza-Puchałka
Jadwiga Zawisza-Puchałka
KKKatarzyna Kujawa
Katarzyna Kujawa
AGAgnieszka Gogler-Pigłowska
Agnieszka Gogler-Pigłowska
JWJoanna Wietrzyk
Joanna Wietrzyk
GGGrzegorz Grynkiewicz
Grzegorz Grynkiewicz

29 October 2013 in BMC Cancer
Verified
Journal Article
Open access
PDF file
NVnatalia vydra
natalia vydra
ATAgnieszka Toma-Jonik
Agnieszka Toma-Jonik
MGMagdalena Głowala-Kosińska
Magdalena Głowala-Kosińska
AGAgnieszka Gogler-Piglowska
Agnieszka Gogler-Piglowska
WWWiesława Widłak
Wiesława Widłak
Heat Shock Transcription Factor 1 (HSF1) is activated under stress conditions. In turn, it induces expression of Heat Shock Proteins (HSPs), which are well-known regulators of protein homeostasis. Elevated levels of HSF1 and HSPs were observed in many types of tumors. The aim of the present study was to determine whether HSF1 could have an effect on the survival of cancer cells treated with chemotherapeutic cytotoxic agents.

1 December 2014 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Open access
JKJoanna Korfanty
Joanna Korfanty
TSTomasz Stokowy
Tomasz Stokowy
PWPiotr Widlak
Piotr Widlak
AGAgnieszka Gogler-Piglowska
Agnieszka Gogler-Piglowska
LHLuiza Handschuh
Luiza Handschuh
WWWiesława Widłak
Wiesława Widłak
Heat Shock Factor 1 (HSF1) is the primary transcription factor responsible for the response to cellular stress, while HSF2 becomes activated during development and differentiation, including spermatogenesis. Although both factors are indispensable for proper spermatogenesis, activation of HSF1 by heat shock initiates apoptosis of spermatogenic cells leading to infertility of males. To characterize mechanisms assisting such heat induced apoptosis we studied how HSF1 and HSF2 cooperate during the heat shock response. For this purpose we used chromatin immunoprecipitation and the proximity ligation approaches. We looked for co-occupation of binding sites by HSF1 and HSF2 in untreated (32 °C) or heat shocked (at 38 °C or 43 °C) spermatocytes, which are cells the most sensitive to hyperthermia. At the physiological temperature or after mild hyperthermia at 38 °C, the sharing of binding sites for both HSFs was observed mainly in promoters of Hsp genes and other stress-related genes. Strong hyperthermia at 43 °C resulted in an increased binding of HSF1 and releasing of HSF2, hence co-occupation of promoter regions was not detected any more. The close proximity of HSF1 and HSF2 (and/or existence of HSF1/HSF2 complexes) was frequent at the physiological temperature. Temperature elevation resulted in a decreased number of such complexes and they were barely detected after strong hyperthermia at 43 °C. We have concluded that at the physiological temperature HSF1 and HSF2 cooperate in spermatogenic cells. However, temperature elevation causes remodeling of chromatin binding and interactions between HSFs are disrupted. This potentially affects the regulation of stress response and contributes to the heat sensitivity of these cells.

7 October 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DSDamian Robert Sojka
Damian Robert Sojka
AGAgnieszka Gogler-Pigłowska
Agnieszka Gogler-Pigłowska
NVnatalia vydra
natalia vydra
ACAlexander Jorge Cortez
Alexander Jorge Cortez
PFPiotr Teodor Filipczak
Piotr Teodor Filipczak
DSDorota Scieglinska
Dorota Scieglinska
Heat shock proteins (HSPs) are a large group of chaperones considered critical for maintaining cellular proteostasis. Their aberrant expression in tumors can modulate the course of processes defined as hallmarks of cancer. Previously, we showed that both stress-inducible HSPA1 and testis-enriched HSPA2, highly homologous members of the HSPA (HSP70) family, are often overexpressed in non-small cell lung carcinoma (NSCLC). HSPA1 is among the best characterized cancer-related chaperones, while the significance of HSPA2 for cancer remains poorly understood. Previously we found that in primary NSCLC, HSPA1 was associated with good prognosis while HSPA2 correlated with bad prognosis, suggesting possible different roles of these proteins in cancer. Therefore, in this work we investigated the impact of HSPA1 and HSPA2 on NSCLC cell phenotype. We found that neither paralog-selective nor simultaneous knockdown of HSPA1 and HSPA2 gene expression reduced growth and chemoresistance of NSCLC cells. Only blocking of HSPA proteins using pan-HSPA inhibitors, VER-155008 or JG-98, exerted potent anticancer effect on NSCLC cells, albeit the final outcome was cell type-dependent. Pan-HSPA inhibition sensitized NSCLC cells to bortezomib, but not to platinum derivates. Our result suggests the inhibitors of proteasome and HSPAs seem an effective drug combination for pre-clinical development in highly aggressive NSCLC.

28 February 2019 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ZKZdzisław Krawczyk
Zdzisław Krawczyk
AGAgnieszka Gogler-Pigłowska
Agnieszka Gogler-Pigłowska
DSDamian Robert Sojka
Damian Robert Sojka
DSDorota Scieglinska
Dorota Scieglinska
Background: Cisplatin (CDDP), a small molecule platinum-based compound, is an effective anticancer drug used against a wide range of human neoplasms. Long-term clinical use of CDDP is however limited due to the development of drug resistance and the possible incidence of serious side effects including nephrotoxicity and ototoxicity. The mechanisms underlying resistance of cells to CDDP are complex, and among them, the cytoprotective involvement of proteins referred to as Heat Shock Proteins (HSP) seems potentially important. Methods: We searched various electronic databases including PubMed and selected the reports concerning the contribution of HSPs to CDDP resistance of cancer cells and to minimize the CDDP-induced nephrotoxicity and ototoxicity. Results: This critical review of data collected so far summarizes the results on the major HSPs: HSP27/HSPB1, HSP70/HSPA1, HSP90/HSPC and GRP78/HSPA5, because only these have been the subject of the most intense research in the matter discussed here. We also provide relevant information concerning some other HSPs, namely HSPA9/mortalin, HSPA2, HSP110 and DNAJ. A possible role of HSPs in counteracting CDDP-induced neprho- and ototoxicity is mentioned. Conclusions: This review shows that no universal relationship between the levels of expression of HSPs and sensitivity of cancer cells to CDDP can be confirmed. Multiple observations indicate however that such correlation can rather manifest as a molecular or cellular context-dependent phenomenon. Thus, HSPs can be viewed as an important component of the multifactorial, complex response of cancer cells to CDDP. However, to strengthen such a conviction, more extensive studies are needed.